"An option to stop the trial for efficacy or futility - neither was demonstrated?"
Overwhelming efficacy. It cannot be ruled out - even at the 45% readout - due to the way the trial is powered. We don't (and can't) have all of the necessary details to determine this, but this table by @omnisearch is a good graphical descriptor:
https://hotcopper.com.au/threads/overwhelming-efficacy-the-stats-required.5579134/page-522?post_id=48623017
You can almost certainly rule out futility of treatment.
MSB Trading 2020 - a new dawn, page-10040
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 86854 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |